Tuesday, March 18, 2025 | 02:21 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Top Headlines: Relief for pharma cos, ban to hit Chinese firms, and more

Here are the top headlines on Wednesday morning

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Premium

BS Web Team New Delhi
After representations from industry bodies, the government on Tuesday cleared imports of active pharma ingredients (APIs) from China. The Kishore Biyani-led Future group has zeroed in on SBI General to sell its majority stake in the general insurance joint venture, and on Premji Invest for its life insurance venture stake. Here are the top headlines on Wednesday morning.

Relief for pharma firms

Easing restrictions on imports from China, the Customs department has decided to clear pharma raw material shipments from that country. Consignments of 11 top importers, including LG, Samsung, Toyota, Honda, and Siemens, will also be allowed entry,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in